AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Adipride M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Adisys Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Adipride M 2mg/500mg Tablet SR

Diabetol Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as advised by your doctor. Lifestyle modifications are crucial for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Uses of Adipride M 2mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Adipride M 2mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Adipride M 2mg/500mg Extended-Release Tablet with a meal.

Common Side effects of Adipride M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Adipride M 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Adipride M 2mg/500mg Sustained-Release Tablets should be administered with food.

How Adipride M 2mg/500mg Tablet SR works:

Adipride M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Adipride M 2mg/500mg SR tablets presents a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Adipride M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Extended-release Adipride M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Adipride M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Adipride M 2mg/500mg SR tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Adipride M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Adipride M 2mg/500mg Tablet SR :

Should you forget to take a dose of Adipride M 2mg/500mg sustained-release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Adipride M 2mg/500mg Tablet SR

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Adipride M 2mg/500mg Tablet SR

Store the medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Adipride M 2mg/500mg Tablet SR. Also termed Metformin-associated lactic acidosis (MALA), this rare complication poses a significant risk to individuals with pre-existing kidney impairment, the elderly, and those who consume substantial alcohol. Manifestations can encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Adipride M 2mg/500mg Tablet SR immediately and seek prompt medical attention.
Adipride M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Adipride M 2mg/500mg sustained-release tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged Adipride M 2mg/500mg SR tablet use can lead to Vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12 intake.
Indeed, Adipride M 2mg/500mg SR tablets can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Adipride M 2mg/500mg sustained-release tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Adipride M 2mg/500mg Tabl...
81
MRP 99
18% off